- Home
- /
- Treatment
- /
- Page 22
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
| Country | Product | Indication | Sponsor | Date |
|---|---|---|---|---|
|
Metformin | Lafora disease | Consorcio Centro de Investigación Biomédica en Red M.P. | December 12, 2016 |
|
Pegylated recombinant human interleukin-10 | Pancreatic Cancer | Larode Ltd | December 12, 2016 |
|
Udenafil | Functional single ventricle congenital heart disease | Mapi Ireland Limited | December 12, 2016 |
|
Nintedanib | Malignant pleural mesothelioma | Boehringer Ingelheim Pharmaceuticals, Inc.;900 Ridgebury Road, P. O. Box 368;Ridgefield, Connecticut, 06877 | December 12, 2016 |
|
Exendin 9-39 (Competitive antagonist of glucagon-like peptide-1) | Hyperinsulinemic hypoglycemia | Eiger BioPharmaceuticals, Inc.;350 Cambridge Avenue, Suite 350;Palo Alto, California, 94306 | December 8, 2016 |
|
Miltefosine | Acanthamoeba keratitis | Profounda, Inc.;5790 Hoffner Avenue, Suite 507;Orlando, Florida, 32822 | December 6, 2016 |
|
Miltefosine | Primary amebic encephalitis (PAM) | Profounda, Inc.;5790 Hoffner Avenue, Suite 507;Orlando, Florida, 32822 | December 6, 2016 |
|
Propanoic acid, 2,2-dimethyl-,1,1′-[[[[4-[[4-hydroxy-3-(phenylmethyl)phenyl]methyl]-3,5-dimethylphenoxy]methyl]phosphinylidene]bis(oxymethylene)] ester | Alport syndrome | Viking Therapeutics, Inc.;12340 El Camino Real, Suite 250;San Diego, California, 92130 | December 5, 2016 |
|
5-{[(3R,4R)-1-(4-chloro-2,6-difluorophenyl)-3,4-dihydroxypiperidin-4-yl]methoxy}-8-fluoro-3,4-dihydroquinolin-2(1H)-one | Active tuberculosis | Otsuka Pharmaceutical Company, Ltd;2440 Research Blvd;Rockville, Maryland, 20850 | December 5, 2016 |
|
Cannabidivarin | Rett syndrome | GW Research Ltd.;Sovereign House, Histon;Cambridge | November 30, 2016 |
|
Riluzole orally disolving tablet | Amyotrophic lateral sclerosis | Biohaven Pharmaceutical Holding Company, Ltd;234 Church Street, Suite 304;New Haven, Connecticut, 06511 | November 30, 2016 |
|
C1 esterase inhibitor (Human) | Acute antibody mediated rejection following kidney transplantation | Shire ViroPharma, Inc.;300 Shire Way;Lexington, Massachusetts, 02421 | November 30, 2016 |
|
Yersinia pestis plague recombinant antigen (rF1V; F1 capsular protein fused to V antigen; E. coli) vaccine with aluminum hydroxide | Pneumonic Plague | DynPort Vaccine Company, LLC, a CSRA Comapny;64 Thomas Johnson Drive;Frederick, Maryland, 21702 | November 30, 2016 |
|
Lactobacillus plantarum | Amyotrophic lateral sclerosis | New Biotic, LLC;19546 Rogan Court;Rowland Heights, California, 91748 | November 30, 2016 |
|
Cannabidiol | Graft Versus Host Disease | Talent biotechs Ltd.;14-18 Baruch Hirsch Street;Bnei Brak | November 29, 2016 |
|
Nanoparticles containing Zoledronic acid | Glioma | Laboratorio Italiano Biochimico Farmaceutico Lisapharma SpA;Via Licinio 11;Erba (CO) | November 29, 2016 |
|
Cellspan esophageal implant | Restore the structure and function of the esophagus subsequent to esophageal damage due to cancer, injury, or congenital abnormality | Biostage, Inc.;84 October Hill Road, Suite 11;Holliston, Massachusetts, 01746 | November 29, 2016 |
|
Risankizumab | pediatric Crohn’s disease | AbbVie Inc.;Regulatory Affair, 1 North Waukegan Road;North Chicago, Illinois, 60044 | November 29, 2016 |
|
(2-((2-chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide) | Multiple myeloma | Acetylon Pharmaceuticals, Inc.;(Celgene Subsidiary), 86 Morris Avenue;Summit, New Jersey, 07901 | November 29, 2016 |
|
Adenovirus associated viral vector serotype 5 containing the RPGR gene | Retinitis pigmentosa | MeiraGTx Limited;450 East 29th Street, 15th Floor;New York, New York, 10016 | November 29, 2016 |
|
Sodium 2-hydroxylinoleate | Pancreatic cancer | Ability Pharmaceuticals, SL;Edifici Eureka, Campus de la UAB;Bellaterra | November 23, 2016 |
|
MRNA encoding human ornithine transcarbamylase | Ornithine Transcarbamylase Deficiency | PhaseRx, Inc.;410 West Harrison Street, Suite 300;Seattle, Washington, 98119 | November 23, 2016 |
|
5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)-pyridin-2-amine | Primary central nervous system lymphoma | PIQUR Therapeutics AG;Hochbergerstrasse 60C, CH-4057 Basel; | November 21, 2016 |
|
Isoindolin-1,3-Di Thione | Frontotemporal dementia | P2D, Inc.;10101 Alliance Road, Suite 105;Cincinnati, Ohio, 45242 | November 21, 2016 |
|
Sodium benzoate | N-acetylglutamate synthetase deficiency | Lucane Pharma SA | November 18, 2016 |
